<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">crystals</journal-id>
      <journal-title>Crystals</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Crystals</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Crystals</abbrev-journal-title>
      <issn pub-type="epub">2073-4352</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/cryst2031108</article-id>
      <article-id pub-id-type="publisher-id">crystals-02-01108</article-id>
      <article-categories>
        <subj-group>
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Synthesis, Characterization and Crystal Structures of 3,5-Bis(4-fluorophenyl)-4,5-dihydro-1<italic>H</italic>-pyrazole-1-carboxamide and 3,5-Bis(4-fluorophenyl)-4,5-dihydro-1<italic>H</italic>-pyrazole-1-carbothioamide</article-title>
      </title-group>
	  <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jasinski</surname>
            <given-names>Jerry P.</given-names>
          </name>
          <xref rid="af1-crystals-02-01108" ref-type="aff">1</xref>
          <xref rid="c1-crystals-02-01108" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Golen</surname>
            <given-names>James A.</given-names>
          </name>
          <xref rid="af1-crystals-02-01108" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Samshuddin</surname>
            <given-names>Seranthimata</given-names>
          </name>
          <xref rid="af2-crystals-02-01108" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Narayana</surname>
            <given-names>Badiadka</given-names>
          </name>
          <xref rid="af2-crystals-02-01108" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yathirajan</surname>
            <given-names>Hemmige S.</given-names>
          </name>
          <xref rid="af3-crystals-02-01108" ref-type="aff">3</xref>
        </contrib>
      </contrib-group>
      
      <aff id="af1-crystals-02-01108"><label>1 </label>Department of Chemistry, Keene State College, 229 Main Street, Keene, NH 03435-2001, USA; Email: <email>jgolen@umassd.edu</email></aff>
      <aff id="af2-crystals-02-01108"><label>2 </label>Department of Studies in Chemistry, Mangalore University, Mangalagangotri-574 199, India; Email: <email>samshu486@gmail.com</email> (S.S.); <email>nbadiadka@yahoo.co.uk</email> (B.N.)</aff>
      <aff id="af3-crystals-02-01108"><label>3 </label>Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore-570 006, India; Email: <email>yathirajan@hotmail.com</email></aff>
      <author-notes>
        <corresp id="c1-crystals-02-01108"><label>*</label> Author to whom correspondence should be addressed; Email: <email>jjasinski@keene.edu</email>; Tel.: +1-603-358-2563.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>15</day>
        <month>08</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="collection">
	  <month>09</month>
        <year>2012</year>
      </pub-date>
      <volume>2</volume>
      <issue>3</issue>
      <fpage>1108</fpage>
      <lpage>1115</lpage>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>06</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>19</day>
          <month>07</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>07</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>©  2012 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (<uri>http://creativecommons.org/licenses/by/3.0/</uri>).</p>
        </license>
      </permissions>
      <abstract>
        <p>Two new pyrazoline derivatives, 3,5-bis(4-fluorophenyl)-4,5-dihydropyrazole-1-carboxamide (<bold>1</bold>) and 3,5-bis(4-fluorophenyl)-4,5-dihydropyrazole-1-carbothioamide (<bold>2</bold>), were synthesized by reacting 4,4'-difluoro chalcone with semicarbazide hydrochloride and thiosemicarbazide in ethanolic sodium hydroxide solution. Both the compounds were confirmed by single crystal X-ray diffraction data and supported by IR, NMR, and mass spectral data. In <bold>1</bold>, crystal packing is stabilized by N–H…O hydrogen bonds and weak N–H...N, N–H…F and C-H…F intermolecular interactions. In <bold>2</bold>, only weak N–H…F and N–H…S intermolecular interactions are observed. Crystal data: C<sub>16</sub>H<sub>13</sub>F<sub>2</sub>N<sub>3</sub>O, (<bold>1</bold>), <italic>M<sub>r</sub></italic>= 301.29, monoclinic, <italic>C</italic>2<italic>/c</italic>, <italic>a</italic> = 17.6219(6) Å, <italic>b</italic> = 10.8735(3) Å, <italic>c</italic> = 15.3216(5) Å, <italic>β</italic> = 102.864(3)°, <italic>V</italic> = 2862.11(16) Å<sup>3</sup>, <italic>Z</italic> = 8, <italic>T </italic>= 173 K, <italic>R</italic>(<italic>F</italic>) = 0.0511, <italic>wR</italic>(<italic>F</italic><sup>2</sup>)= 0.1333; C<sub>16</sub>H<sub>13</sub>F<sub>2</sub>N<sub>3</sub>S, (<bold>2</bold>), <italic>M<sub>r</sub></italic> = 317.35, monoclinic, <italic>P</italic>2<sub>1</sub><italic>/c</italic>, <italic>a</italic> = 14.339(2) Å, <italic>b</italic> = 11.1478(17) Å, <italic>c</italic> = 9.541(2)(5) Å, <italic>β</italic> = 107.007(18)°, <italic>V</italic> = 1458.5(5) Å<sup>3</sup>, <italic>Z</italic> = 4, <italic>T </italic>= 173 K, <italic>R</italic>(<italic>F</italic>) = 0.0413, <italic>wR</italic>(<italic>F</italic><sup>2</sup>)= 0.0959.</p>
      </abstract>
      <kwd-group>
        <kwd>pyrazoline derivatives</kwd>
        <kwd>X-ray crystal structure</kwd>
        <kwd>hydrogen bonds</kwd>
        <kwd>weak intermolecular interactions</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>1. Introduction</title>
      <p>Pyrazolines are well known, and important nitrogen-containing five-membered heterocyclic compounds and various methods have been reported for their synthesis [<xref ref-type="bibr" rid="B1-crystals-02-01108">1</xref>,<xref ref-type="bibr" rid="B2-crystals-02-01108">2</xref>]. Substituted pyrazolines are useful in pharmaceutical and agrochemical research. They display various biological activities such as antitumor, antibacterial, antifungal, antiviral, antiparasitic, anti-tubercular and insecticidal [<xref ref-type="bibr" rid="B3-crystals-02-01108">3</xref>,<xref ref-type="bibr" rid="B4-crystals-02-01108">4</xref>,<xref ref-type="bibr" rid="B5-crystals-02-01108">5</xref>]. Some of these compounds have also antioxidant, anti-inflammatory and analgesic properties [<xref ref-type="bibr" rid="B6-crystals-02-01108">6</xref>,<xref ref-type="bibr" rid="B7-crystals-02-01108">7</xref>]. Due to these interesting activities of diversely substituted pyrazolines as biological agents, considerable attention has been focused on this class. In addition, pyrazolines have played a crucial part in the development of the theory in heterocyclic chemistry and also used extensively in organic synthesis [<xref ref-type="bibr" rid="B8-crystals-02-01108">8</xref>]. </p>
      <p>Crystal structures of some 3,5-diaryl-4,5-dihydropyrazoles substituted at position 1 with carboxamide or carbothioamide groups, viz., 4,5-dihydro-3-methyl-5-(4-methylphenyl)-1<bold><italic>H</italic></bold>-pyrazole-1-carboxamide [<xref ref-type="bibr" rid="B9-crystals-02-01108">9</xref>] and 3-(4-bromophenyl)-5-[4-(dimethylamino)phenyl]-4,5-dihydro-1<bold><italic>H</italic></bold>-pyrazole-1-carbothioamide [<xref ref-type="bibr" rid="B10-crystals-02-01108">10</xref>] have been reported.</p>
      <p>In view of the importance of pyrazolines and in continuation of our work on synthesis of various derivatives of 4,4'-difluoro chalcones [<xref ref-type="bibr" rid="B11-crystals-02-01108">11</xref>,<xref ref-type="bibr" rid="B12-crystals-02-01108">12</xref>,<xref ref-type="bibr" rid="B13-crystals-02-01108">13</xref>,<xref ref-type="bibr" rid="B14-crystals-02-01108">14</xref>,<xref ref-type="bibr" rid="B15-crystals-02-01108">15</xref>,<xref ref-type="bibr" rid="B16-crystals-02-01108">16</xref>,<xref ref-type="bibr" rid="B17-crystals-02-01108">17</xref>,<xref ref-type="bibr" rid="B18-crystals-02-01108">18</xref>], we report the synthesis and crystal structures of new 3,5-bis(4-fluorophenyl)-4,5-dihydropyrazoles substituted at position 1 with carboxamide or carbothioamide groups (<xref ref-type="fig" rid="crystals-02-01108-f001">Figure 1</xref>).</p>
      <fig id="crystals-02-01108-f001" position="anchor">
        <label>Figure 1</label>
        <caption>
          <p>The molecular structures of (<bold>1</bold>) C<sub>16</sub>H<sub>13</sub>F<sub>2</sub>N<sub>3</sub>O and (<bold>2</bold>)C<sub>16</sub>H<sub>13</sub>F<sub>2</sub>N<sub>3</sub>S.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="crystals-02-01108-g001.tif"/>
      </fig>
    </sec>
    <sec sec-type="results">
      <title>2. Results and Discussion</title>
      <p>The IR spectrum of compound <bold>1</bold> (Figure S1) showed a forked band at 3452 cm<sup>−1</sup> corresponding to NH<sub>2</sub> group and a band at 1681 cm<sup>−1</sup> assigned to the carbonyl group. While, the IR spectrum of compound <bold>2</bold> (Figure S2) demonstrated a forked band at 3475 cm<sup>−1</sup> corresponding to a NH<sub>2</sub>– group and a band at 1365 cm<sup>−1</sup> corresponding to a C=S group. The IR spectra of both the compounds showed a –C=N–stretch at 1577 &amp; 1599 cm<sup>−</sup><sup>1</sup>, which confirmed the formation of the pyrazoline moiety. In the <sup>1</sup>H NMR spectra of pyrazolines (Figures S3 and S4), protons H<sub>A</sub> and H<sub>B</sub> are geminal protons at the C4 carbon. They appeared in the region 3.03–3.12 ppm and 3.75–3.84 ppm as a doublet of doublets for both the compounds. The CH proton at C5 also appeared as a doublet of doublets in the region of 5.38–5.89 ppm, due to vicinal coupling with two non-equivalent geminal protons of the C4 carbon. Beside these signals, the amino protons appeared as broad singlet signal at δ 6.5 in compound <bold>1</bold> and as two singlet signals at δ 7.95 &amp; 8.02 in compound <bold>2</bold>. LCMS (Figures S5 and S6) and elemental analysis also gave satisfactory results for both of the compounds.</p>
      <p>In the crystal structures, the dihedral angle between the pyrazole ring and the two benzene rings is 1.9(1) Å and 55.9(6) Å in <bold>1</bold> (<xref ref-type="fig" rid="crystals-02-01108-f002">Figure 2</xref>) and 15.1(1) Å and 80.9(8) Å in <bold>2</bold> (<xref ref-type="fig" rid="crystals-02-01108-f003">Figure 3</xref>), respectively. </p>
      <fig id="crystals-02-01108-f002" position="anchor">
        <label>Figure 2</label>
        <caption>
          <p>Molecular structure of <bold>1</bold> showing the atom labeling scheme and 50% probabilitydisplacement ellipsoids.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="crystals-02-01108-g002.tif"/>
      </fig>
      <fig id="crystals-02-01108-f003" position="anchor">
        <label>Figure 3</label>
        <caption>
          <p>Molecular structure of <bold>2</bold> showing the atom labeling scheme and 50% probabilitydisplacement ellipsoids.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="crystals-02-01108-g003.tif"/>
      </fig>
      <p>Bond lengths are in normal ranges for <bold>1</bold> and <bold>2</bold> [<xref ref-type="bibr" rid="B19-crystals-02-01108">19</xref>]. Selected bond lengths and angles for both molecules are listed in <xref ref-type="table" rid="crystals-02-01108-t001">Table 1</xref>. </p>
      <table-wrap id="crystals-02-01108-t001" position="anchor">
        <object-id pub-id-type="pii">crystals-02-01108-t001_Table 1</object-id>
        <label>Table 1</label>
        <caption>
          <p>Selected atom distances [Å] for <bold>1</bold> and <bold>2</bold>.</p>
        </caption>
        <table>
          <thead>
            <tr>
              <th align="center" valign="middle">Atoms 1</th>
              <th align="center" valign="middle">Distance 1</th>
              <th align="center" valign="middle">Atoms 2</th>
              <th align="center" valign="middle">Distance 2</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="center" valign="middle">C1—O1</td>
              <td align="center" valign="middle">1.2300(19)</td>
              <td align="center" valign="middle">C1—S1</td>
              <td align="center" valign="middle">1.6818(16)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">C1—N1</td>
              <td align="center" valign="middle">1.340(2)</td>
              <td align="center" valign="middle">C1—N1</td>
              <td align="center" valign="middle">1.331(2)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">N2—N3</td>
              <td align="center" valign="middle">1.3929(17)</td>
              <td align="center" valign="middle">N2—N3</td>
              <td align="center" valign="middle">1.3924(17)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">N2—C2</td>
              <td align="center" valign="middle">1.4754(19)</td>
              <td align="center" valign="middle">N2—C2</td>
              <td align="center" valign="middle">1.4761(19)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">N3—C4</td>
              <td align="center" valign="middle">1.2804(19)</td>
              <td align="center" valign="middle">N3—C4</td>
              <td align="center" valign="middle">1.283(2)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">C2—C3</td>
              <td align="center" valign="middle">1.544(2)</td>
              <td align="center" valign="middle">C2—C3</td>
              <td align="center" valign="middle">1.538(2)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">C3—C4</td>
              <td align="center" valign="middle">1.498(2)</td>
              <td align="center" valign="middle">C3—C4</td>
              <td align="center" valign="middle">1.501(2)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">C8—F1</td>
              <td align="center" valign="middle">1.358(2)</td>
              <td align="center" valign="middle">C8—F1</td>
              <td align="center" valign="middle">1.356(2)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">C14—F2</td>
              <td align="center" valign="middle">1.3658(18)</td>
              <td align="center" valign="middle">C14—F2</td>
              <td align="center" valign="middle">1.3665(19)</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>In <bold>1</bold>, the molecules in the crystal form an inversion dimer through a pair of N–H…O, hydrogen bonds. These dimers are further linked through weak N–H…F and C–H…F intermolecular interactions (<xref ref-type="table" rid="crystals-02-01108-t002">Table 2</xref>) into a sheet-like structure in the ac-plane (<xref ref-type="fig" rid="crystals-02-01108-f004">Figure 4</xref>). In addition, weak π—π intermolecular interactions (Cg1…Cg2; 3.9841(11) Å; 1 − <italic>x</italic>, 1 − <italic>y</italic>, 1 − <italic>z</italic>, and Cg1…Cg3; 3.8319(9) Å, <italic>x</italic>, <italic>y</italic>, <italic>z</italic> where Cg1 = centroid for N2/N3/C4/C3/C2, Cg2 = centroid for C5—C10, Cg3 = centroid for C11—C16) are observed which help stabilize crystal packing. </p>
      <table-wrap id="crystals-02-01108-t002" position="anchor">
        <object-id pub-id-type="pii">crystals-02-01108-t002_Table 2</object-id>
        <label>Table 2</label>
        <caption>
          <p>Hydrogen bonds for <bold>1</bold>, C<sub>16</sub>H<sub>13</sub>F<sub>2</sub>N<sub>3</sub>O [Å and °].</p>
        </caption>
        <table>
          <thead>
            <tr>
              <th align="center" valign="middle">D–H...A</th>
              <th align="center" valign="middle">d (D–H)</th>
              <th align="center" valign="middle">d (H...A)</th>
              <th align="center" valign="middle">d (D...A)</th>
              <th align="center" valign="middle">&lt; (DHA)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="center" valign="middle">N1–H1NA...O1 <sup>#1</sup></td>
              <td align="center" valign="middle">0.88(2)</td>
              <td align="center" valign="middle">2.06(2)</td>
              <td align="center" valign="middle">2.928(2)</td>
              <td align="center" valign="middle">171(2)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">N1–H1NB...F2 <sup>#2</sup></td>
              <td align="center" valign="middle">0.88(2)</td>
              <td align="center" valign="middle">2.38(2)</td>
              <td align="center" valign="middle">3.129(2)</td>
              <td align="center" valign="middle">143(2)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">C13–H13A...F1 <sup>#3</sup></td>
              <td align="center" valign="middle">0.93</td>
              <td align="center" valign="middle">2.54</td>
              <td align="center" valign="middle">3.386(2)</td>
              <td align="center" valign="middle">151</td>
            </tr>
          </tbody>
        </table>
		<table-wrap-foot><fn><p>Symmetry transformations used to generate equivalent atoms: <sup>#1</sup> –<italic>x</italic> + 1, −<italic>y</italic> + 2, −<italic>z</italic> + 1; <sup>#2</sup><italic>x</italic> − 1/2, −<italic>y</italic> + 3/2, <italic>z</italic> − 1/2; <sup>#3</sup> –<italic>x</italic> + 1, <italic>y</italic> + 1, −<italic>z</italic> + 3/2. </p></fn></table-wrap-foot>
      </table-wrap>
      <fig id="crystals-02-01108-f004" position="anchor">
        <label>Figure 4</label>
        <caption>
          <p>Packing diagram of 1 viewed along the <italic>b</italic> axis. Dashed lines indicate N–H...Ohydrogen bonds forming an inversion dimer. Additional weak N–H…F and C–H…F intermolecular interactions further link the molecules into a sheet-like structure in the ac-plane. Remaining H atoms have been removed for clarity.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="crystals-02-01108-g004.tif"/>
      </fig>
      
      <p>In <bold>2</bold>, N–H…F and N–H…S hydrogen bonds are observed creating an infinite 1-D chain along (001) which along with weak C–H…Cg π-ring intermolecular interactions (<xref ref-type="table" rid="crystals-02-01108-t003">Table 3</xref>) strongly influence crystal packing (<xref ref-type="fig" rid="crystals-02-01108-f005">Figure 5</xref>). </p>
      <table-wrap id="crystals-02-01108-t003" position="anchor">
        <object-id pub-id-type="pii">crystals-02-01108-t003_Table 3</object-id>
        <label>Table 3</label>
        <caption>
          <p>Hydrogen bonds for <bold>2</bold>, C<sub>16</sub>H<sub>13</sub>F<sub>2</sub>N<sub>3</sub>S [Å and °].</p>
        </caption>
        <table>
          <thead>
            <tr>
              <th align="center" valign="middle">D–H...A</th>
              <th align="center" valign="middle">d (D–H)</th>
              <th align="center" valign="middle">d (H...A)</th>
              <th align="center" valign="middle">d (D...A)</th>
              <th align="center" valign="middle">&lt; (DHA)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="center" valign="middle">N1–H1NB...F2<sup>#1</sup></td>
              <td align="center" valign="middle">0.87(2)</td>
              <td align="center" valign="middle">2.41(2)</td>
              <td align="center" valign="middle">3.258(2)</td>
              <td align="center" valign="middle">164(2)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">N1–H1NA...S1<sup>#2</sup></td>
              <td align="center" valign="middle">0.84(2)</td>
              <td align="center" valign="middle">2.85(2)</td>
              <td align="center" valign="middle">3.525(2)</td>
              <td align="center" valign="middle">138(2)</td>
            </tr>
          </tbody>
        </table>
		<table-wrap-foot><fn><p>Symmetry transformations used to generate equivalent atoms: <sup>#1</sup><italic>x</italic>, <italic>y</italic>, <italic>z</italic>−1; <sup>#2</sup><italic>x</italic>, −<italic>y</italic> + 3/2, <italic>z</italic> − 1/2.</p></fn></table-wrap-foot>
      </table-wrap>
      <fig id="crystals-02-01108-f005" position="anchor">
        <label>Figure 5</label>
        <caption>
          <p>Packing diagram of <bold>2</bold> viewed along the <italic>b</italic> axis. Dashed lines indicate N–H...F and N–H...S hydrogen bonds forming chains along (001). Remaining H atoms have been removedfor clarity.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="crystals-02-01108-g005.tif"/>
      </fig>
      
    </sec>
    <sec>
      <title>3. Experimental Section</title>
      <sec>
        <title>3.1. General</title>
        <p>The synthesis of the target compounds is outlined in <xref ref-type="scheme" rid="crystals-02-01108-f006">Scheme 1</xref>. 4,4'-Difluoro chalcone was reacted with semicarbazide HCl or thiosemicarbazide in ethanolic NaOH to afford 3,5-bis(4-fluorophenyl)-4,5-dihydropyrazole-1-carboxamide (<bold>1</bold>) and 3,5-bis(4-fluorophenyl)-4,5-dihydropyrazole-1-carbothioamide (<bold>2</bold>) respectively.</p>
        <fig id="crystals-02-01108-f006" position="anchor">
          <object-id pub-id-type="pii">crystals-02-01108-scheme1_Scheme 1</object-id>
          <label>Scheme 1</label>
          <caption>
            <p>The synthesis of <bold>1</bold> and <bold>2</bold>.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="crystals-02-01108-g006.tif"/>
        </fig>
        <p>Melting points were taken in open capillary tubes and were uncorrected. The purity of the compounds was confirmed by thin layer chromatography using Merck silica gel 60 F254 coated aluminum plates. IR spectra were recorded on Shimadzu-FTIR Infrared spectrometer in KBr (mmax in cm<sup>−1</sup>). <sup>1</sup>H (400 MHz) NMR spectra were recorded on a Bruker AMX 400 spectrometer, with 5 mm PABBO BB −1H TUBES with TMS as internal standard. LCMS was obtained using Agilent 1200 series LC and Micromass zQ spectrometer. Elemental analyses were carried out by using VARIO EL-III (Elementar Analysensysteme GmBH).</p>
      </sec>
      <sec>
        <title>3.2. Synthesis of 3,5-Bis(4-fluorophenyl)-4,5-dihydro-1<italic>H</italic>-pyrazole-1-carboxamide (1)</title>
        <p>A mixture of 4,4'-difluoro chalcone (1.22 g, 0.005 mol), semicarbazide HCl (0.6 g, 0.005 mol) and NaOH (0.5 g, 0.0125 mol) was heated under reflux in absolute ethanol (12.5 mL) for 12 h. The reaction mixture was cooled and poured into ice cold water. The solid separated was filtered, dried and recrystallized from ethanol. The single crystals were grown from DMF by slow evaporation method and yield of the compound was 78%. (m.p. 435 K).</p>
        <p>IR (KBr, cm<sup>−1</sup>): 3452, 3211 (NH<sub>2</sub>), 1681 (C=O), 1599 (C=N), 1224 (C–F); <sup>1</sup>H NMR (400 MHz, DMSO) δ ppm 3.03 (dd, 1H, H<sub>A</sub>, J = 5.2 Hz,), 3.75 (dd, 1H, H<sub>B</sub>, J = 12 Hz), 5.38 (dd, 1H, H<sub>X</sub>, J = 5.60 Hz), 6.50 (br s, 2H, NH<sub>2</sub>), 7.11–7.85 (m, 8H, Ar–H); LCMS: m/z 301.9 (M<sup>+</sup>); Analytical data: Found (Cald): C%: 63.72 (63.78); H%: 4.34 (4.35); N%: 13.91 (13.95).</p>
      </sec>
      <sec>
        <title>3.3. Synthesis of 3,5-Bis(4-fluorophenyl)-4,5-dihydro-1<italic>H</italic>-pyrazole-1-carbothioamide (2)</title>
        <p>A mixture of 4,4'-difluoro chalcone (1.22 g, 0.005 mol), thiosemicarbazide (0.46 g, 0.005 mol) and NaOH (0.5 g, 0.0125 mol) was heated under reflux in absolute ethanol (12.5 mL) for 16 h. The reaction mixture was cooled and poured into ice cold water. The solid separated was filtered, dried and recrystallized ethanol. The single crystals were grown from DMF by slow evaporation method and yield of the compound was 72%. (m.p. 526 K). </p>
        <p>IR (KBr, cm<sup>−1</sup>): 3475, 3354 (NH<sub>2</sub>), 1577 (C=N), 1365 (C=S), 1213 (C–F). <sup>1</sup>H NMR (400 MHz, DMSO) δ ppm 3.12 (dd, 1H, H<sub>A</sub>, J = 3.6 Hz), 3.84 (dd, 1H, H<sub>B</sub>, J = 11.6 Hz), 5.89 (dd, 1H, H<sub>X</sub>, J = 3.6 Hz), 7.11–7.94 (m, 8H, Ar–H), 7.95 &amp; 8.02 (two s, 2H, NH<sub>2</sub>); LCMS: <italic>m</italic>/<italic>z</italic> 317.9 (M<sup>+</sup>); Analytical data: Found (Cald): C%: 60.52 (60.55); H%: 4.15 (4.13); N%: 13.22 (13.24).</p>
      </sec>
      <sec>
        <title>3.4. Data Collection and Refinement</title>
        <p>Crystallographic data for both <bold>1</bold> and <bold>2</bold> were collected on an Agilent Gemini CCD-Diffractometer with monochromatic Mo-K<italic>α</italic> radiation (<italic>λ</italic> = 0.71073 Å) and an EOS detector [<xref ref-type="bibr" rid="B20-crystals-02-01108">20</xref>]. The structures were solved by direct methods [<xref ref-type="bibr" rid="B21-crystals-02-01108">21</xref>], full-matrix least-squares refinement [<xref ref-type="bibr" rid="B21-crystals-02-01108">21</xref>] on <italic>F</italic><sup>2</sup> with 313 <bold>1</bold> or 219 <bold>2</bold> parameters. In both <bold>1</bold> and <bold>2</bold>, H1NA, and H1NB, were located in a difference map and refined isotropically. All of the remaining H atoms were placed in their calculated positions and then refined using the riding model with C–H lengths of 0.93 or 0.98 Å (CH) or 0.97 Å (CH<sub>2</sub>). The isotropic displacement parameters for these atoms were set to 1.19 to 1.20 (CH, CH<sub>2</sub>), times U<sub>eq</sub> of the parent atom.</p>
        <p>Crystal data for <bold>1</bold>: colorless chunk, 0.22 × 0.21 × 0.20 mm, C<sub>16</sub>H<sub>13</sub>F<sub>2</sub>N<sub>3</sub>O, <italic>M<sub>r</sub></italic> = 301.29, monoclinic <italic>C</italic>2/<italic>c</italic>, <italic>a</italic> = 17.6219(6) Å, <italic>b</italic> = 10.8735(3) Å, <italic>c </italic>= 15.3216(5) Å, <italic>β</italic> = 102.864(3)° and <italic>V</italic> = 2862.11(16) Å<sup>3</sup>, <italic>Z</italic> = 8, <italic>F</italic>(000) = 1248, <italic>T</italic> = 173(2) K, <italic>ρ</italic><sub>calc</sub> = 1.398 g·cm<sup>−3</sup>, <italic>μ</italic> = 0.108 mm<sup>−1</sup>, 12815 reflections measured (−22 ≤ <italic>h</italic> ≤ 23, −14 ≤ <italic>k</italic> ≤ 13, −20 ≤ <italic>l</italic> ≤ 19; 3.2974 ≤ <italic>θ</italic> ≤ 32.3351), <italic>R</italic><sub>int</sub> = 0.0220, 3684 merged reflections, I &gt; 2<italic>σ</italic>(I), 205 parameters, 2 restraints, GOF = 1.011, <italic>R</italic>(<italic>F</italic>) = 0.0511, <italic>wR</italic>(<italic>F</italic><sup>2</sup>) = 0.1333, <italic>w </italic>= 1/<italic>σ</italic><sup>2</sup>(<italic>F</italic><sub>o</sub><sup>2</sup>) + 0.0541<italic>P</italic><sup>2</sup>, where <italic>P </italic>= (<italic>F</italic><sub>o</sub><sup>2</sup> + 2<italic>F</italic><sub>c</sub><sup>2</sup>)/3, min./max. ∆<italic>ρ</italic> = −0.38, +0.37 <italic>e </italic>Å<sup>3</sup>. Cambridge Database deposition number: CSD-888442.</p>
        <p>Crystal data for <bold>2</bold>: colorless chunk, 0.20 × 0.16 × 0.12 mm, C<sub>16</sub>H<sub>13</sub>F<sub>2</sub>N<sub>3</sub>S, <italic>M<sub>r</sub></italic> = 317.35, monoclinic <italic>P</italic>2<sub>1</sub>/<italic>c</italic>, <italic>a</italic> = 14.339(2) Å, <italic>b</italic> = 11.1478(17) Å, <italic>c </italic>= 9.541(2) Å, <italic>β</italic> = 107.007(18)° and <italic>V</italic> = 1458.5(5) Å<sup>3</sup>, <italic>Z</italic> = 4, <italic>F</italic>(000) = 656, <italic>T</italic> = 173(2) K, <italic>ρ</italic><sub>calc</sub> = 1.445 g·cm<sup>−3</sup>, <italic>μ</italic> = 0.243 mm<sup>−1</sup>, 13239 reflections measured (−18 ≤ <italic>h</italic> ≤ 18, −14 ≤ <italic>k</italic> ≤ 14, −11 ≤ <italic>l</italic> ≤ 12; 2.9651 ≤ <italic>θ</italic> ≤ 30.0998), <italic>R</italic><sub>int</sub> = 0.0331, 3483 merged reflections, I &gt; 2<italic>σ</italic>(I), 205 parameters, 2 restraints, GOF 1.004, <italic>R</italic>(<italic>F</italic>) = 0.0413, <italic>wR</italic>(<italic>F</italic><sup>2</sup>) = 0.0959, <italic>w </italic>= 1/<italic>σ</italic><sup>2</sup>(<italic>F</italic><sub>o</sub><sup>2</sup>) + 0.0541<italic>P</italic><sup>2</sup>, where <italic>P </italic>= (<italic>F</italic><sub>o</sub><sup>2</sup> + 2<italic>F</italic><sub>c</sub><sup>2</sup>)/3, min./max. <italic>∆ρ</italic> = −0.216, +0.213 <italic>e </italic>Å<sup>3</sup>. Cambridge Database deposition number: CSD-888534.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions">
      <title>4. Conclusions</title>
      <p>The crystal and molecular structures of 3,5-bis(4-fluorophenyl)-4,5-dihydro-1<italic>H</italic>-pyrazole-1-carboxamide (<bold>1</bold>) and 3,5-bis(4-fluorophenyl)-4,5-dihydro-1<italic>H</italic>-pyrazole-1-carbothioamide (<bold>2</bold>), and spectroscopic supporting data are reported. These data represent crystallographically characterized compounds of two new pyrazoline derivatives which are potentially useful in pharmaceutical and agrochemical research. The effects of hydrogen bonding and weak intermolecular interactions observed in both molecules influence crystal packing as described.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>BN thanks the UGC SAP for financial assistance for the purchase of chemicals. SS thanks Mangalore University for research facilities. JPJ acknowledges the NSF--MRI program (grant No.CHE1039027) for funds to purchase the X-ray diffractometer.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1-crystals-02-01108">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fustero</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Simon-Fuentes</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sanz-Cervera</surname>
              <given-names>J.F.</given-names>
            </name>
          </person-group>
          <article-title>Recent advances in the synthesis of pyrazoles. A review</article-title>
          <source>Org. Prep. Proced. Int.</source>
          <year>2009</year>
          <volume>41</volume>
          <fpage>253</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="doi">10.1080/00304940903077832</pub-id>
        </citation>
      </ref>
      <ref id="B2-crystals-02-01108">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rajendra</surname>
              <given-names>P.Y.</given-names>
            </name>
            <name>
              <surname>Lakshmana</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Prasoona</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Murali</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ravi</surname>
              <given-names>K.P.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2''-hydroxy naphthalen-1''-yl)-1,5-diphenyl-2-pyrazolines</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2005</year>
          <volume>15</volume>
          <fpage>5030</fpage>
          <lpage>5034</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2005.08.040</pub-id>
        </citation>
      </ref>
      <ref id="B3-crystals-02-01108">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amir</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>S.A.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and pharmacological evaluation of pyrazoline derivatives as new anti-inflammatory and analgesic agents</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2008</year>
          <volume>18</volume>
          <fpage>918</fpage>
          <lpage>922</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2007.12.043</pub-id>
        </citation>
      </ref>
      <ref id="B4-crystals-02-01108">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hes</surname>
              <given-names>R.V.</given-names>
            </name>
            <name>
              <surname>Wellinga</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Grosscurt</surname>
              <given-names>A.C.</given-names>
            </name>
          </person-group>
          <article-title>1-Phenylcarbamoyl-2-pyrazolines, a new class of insecticides. 2. Synthesis and insecticidal properties of 3,5-diphenyl-1-phenylcarbamoyl-2-pyrazolines</article-title>
          <source>J. Agric. Food Chem.</source>
          <year>1978</year>
          <volume>26</volume>
          <fpage>915</fpage>
          <lpage>918</lpage>
          <pub-id pub-id-type="doi">10.1021/jf60218a015</pub-id>
        </citation>
      </ref>
      <ref id="B5-crystals-02-01108">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grosscurt</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Hes</surname>
              <given-names>R.V.</given-names>
            </name>
            <name>
              <surname>Wellnga</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>1-Phenylcarbamoyl-2-pyrazolines, a new class of insecticides. 3. Synthesis and insecticidal properties of 3,4-diphenyl-1-phenylcarbamoyl-2-pyrazolines</article-title>
          <source>J. Agric. Food Chem.</source>
          <year>1979</year>
          <volume>27</volume>
          <fpage>406</fpage>
          <lpage>409</lpage>
          <pub-id pub-id-type="doi">10.1021/jf60222a061</pub-id>
        </citation>
      </ref>
      <ref id="B6-crystals-02-01108">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sarojini</surname>
              <given-names>B.K.</given-names>
            </name>
            <name>
              <surname>Vidyagayatri</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Darshanraj</surname>
              <given-names>C.G.</given-names>
            </name>
            <name>
              <surname>Bharath</surname>
              <given-names>B.R.</given-names>
            </name>
            <name>
              <surname>Manjunatha</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>DPPH scavenging assay of novel 1,3-disubstituted-1H-pyrazol-5-ols and their in silico studies on some proteins involved in Alzheimer’s disease signaling cascade</article-title>
          <source>Lett. Drug Des. Discov.</source>
          <year>2010</year>
          <volume>7</volume>
          <fpage>214</fpage>
          <lpage>224</lpage>
        <pub-id pub-id-type="doi">10.2174/157018010790596588</pub-id></citation>
      </ref>
      <ref id="B7-crystals-02-01108">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amir</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis, anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of 3,5-dimethylpyrazoles, 3-methyl pyrazol-5-ones and 3,5-disubstituted pyrazolines</article-title>
          <source>Indian J. Chem.</source>
          <year>2005</year>
          <volume>44</volume>
          <fpage>2532</fpage>
          <lpage>2537</lpage>
          <pub-id pub-id-type="doi">10.1021/ie0495729</pub-id>
        </citation>
      </ref>
      <ref id="B8-crystals-02-01108">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klimova</surname>
              <given-names>E.I.</given-names>
            </name>
            <name>
              <surname>Marcos</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Klimova</surname>
              <given-names>T.B.</given-names>
            </name>
            <name>
              <surname>Cecilio</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Ruben</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Lena</surname>
              <given-names>R.R.</given-names>
            </name>
          </person-group>
          <article-title>The structure of bicyclic ferrocenylmethylene substituted 2-pyrazolines and their reactions with azodicarboxylic acid <italic>N</italic>-phenylimide</article-title>
          <source>J. Organomet. Chem.</source>
          <year>1999</year>
          <volume>585</volume>
          <fpage>106</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-328X(99)00202-8</pub-id>
        </citation>
      </ref>
      <ref id="B9-crystals-02-01108">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kettmann</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Svetlík</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>4,5-Dihydro-3-methyl-5-(4-methylphenyl)-1<italic>H</italic>-pyrazole-1-carboxamide</article-title>
          <source>Acta Cryst.</source>
          <year>2003</year>
          <volume>C59</volume>
          <fpage>o419</fpage>
          <lpage>o421</lpage>
        </citation>
      </ref>
      <ref id="B10-crystals-02-01108">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fun</surname>
              <given-names>H.K.</given-names>
            </name>
            <name>
              <surname>Suwunwong</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Chantrapromma</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>3-(4-Bromophenyl)-5-[4-(dimethylamino)phenyl]-4,5-dihydro-1<italic>H</italic>-pyrazole-1-carbothioamide</article-title>
          <source>Acta Cryst.</source>
          <year>2011</year>
          <volume>E67</volume>
          <fpage>o701</fpage>
          <lpage>o702</lpage>
        </citation>
      </ref>
      <ref id="B11-crystals-02-01108">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Samshuddin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Narayana</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Shetty</surname>
              <given-names>D.N.</given-names>
            </name>
            <name>
              <surname>Raghavendra</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>An efficient synthesis of 2,4,6-triarylpyridines and their biological evaluation</article-title>
          <source>Der Pharma Chemica</source>
          <year>2011</year>
          <volume>3</volume>
          <fpage>232</fpage>
          <lpage>240</lpage>
        </citation>
      </ref>
      <ref id="B12-crystals-02-01108">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Samshuddin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Butcher</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Akkurt</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Narayana</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Yathirajan</surname>
              <given-names>H.S.</given-names>
            </name>
            <name>
              <surname>Sarojini</surname>
              <given-names>B.K.</given-names>
            </name>
          </person-group>
          <article-title>1,3-Bis(4-fluorophenyl)-<italic>N</italic>,<italic>N</italic>'-(propane-1,3-diylidene) dihydroxylamine</article-title>
          <source>Acta Cryst.</source>
          <year>2011</year>
          <volume>E67</volume>
          <fpage>o1954</fpage>
          <lpage>o1955</lpage>
        </citation>
      </ref>
      <ref id="B13-crystals-02-01108">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jasinski</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Guild</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Samshuddin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Narayana</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Yathirajan</surname>
              <given-names>H.S.</given-names>
            </name>
          </person-group>
          <article-title>2,3-Dibromo-1,3-bis(4-fluorophenyl)propan-1-one</article-title>
          <source>Acta Cryst.</source>
          <year>2010</year>
          <volume>E66</volume>
          <fpage>o2018</fpage>
        </citation>
      </ref>
      <ref id="B14-crystals-02-01108">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jasinski</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Guild</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Samshuddin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Narayana</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Yathirajan</surname>
              <given-names>H.S.</given-names>
            </name>
          </person-group>
          <article-title>3,5-Bis(4-fluorophenyl)-1-phenyl-4,5-dihydro-1<italic>H</italic>-pyrazole</article-title>
          <source>Acta Cryst.</source>
          <year>2010</year>
          <volume>E66</volume>
          <fpage>o1948</fpage>
          <lpage>o1949</lpage>
        </citation>
      </ref>
      <ref id="B15-crystals-02-01108">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fun</surname>
              <given-names>H.K.</given-names>
            </name>
            <name>
              <surname>Hemamalini</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Samshuddin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Narayana</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Yathirajan</surname>
              <given-names>H.S.</given-names>
            </name>
          </person-group>
          <article-title>1-[3,5-Bis(4-fluorophenyl)-4,5-dihydro-1<italic>H</italic>-pyrazol-1-yl]ethanone</article-title>
          <source>Acta Cryst.</source>
          <year>2010</year>
          <volume>E66</volume>
          <fpage>o582</fpage>
          <lpage>o583</lpage>
        </citation>
      </ref>
      <ref id="B16-crystals-02-01108">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fun</surname>
              <given-names>H.K.</given-names>
            </name>
            <name>
              <surname>Hemamalini</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Samshuddin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Narayana</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Yathirajan</surname>
              <given-names>H.S.</given-names>
            </name>
          </person-group>
          <article-title>Methyl-4,6-bis(4-fluorophenyl)-2-oxocyclohex-3-ene-1-carboxylate</article-title>
          <source>Acta Cryst.</source>
          <year>2010</year>
          <volume>E66</volume>
          <fpage>o864</fpage>
          <lpage>o865</lpage>
        </citation>
      </ref>
      <ref id="B17-crystals-02-01108">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baktir</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Akkurt</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Samshuddin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Narayana</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Yathirajan</surname>
              <given-names>H.S.</given-names>
            </name>
          </person-group>
          <article-title>2,4-Bis(4-fluorophenyl)-2,3-dihydro-1<italic>H</italic>-1,5-benzodiazepine</article-title>
          <source>Acta Cryst.</source>
          <year>2011</year>
          <volume>E67</volume>
          <fpage>o1262</fpage>
        </citation>
      </ref>
      <ref id="B18-crystals-02-01108">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baktir</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Akkurt</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Samshuddin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Narayana</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Yathirajan</surname>
              <given-names>H.S.</given-names>
            </name>
          </person-group>
          <article-title>3,5-Bis(4-fluorophenyl)-4,5-dihydro-1<italic>H</italic>-pyrazole-1-carbaldehyde</article-title>
          <source>Acta Cryst.</source>
          <year>2011</year>
          <volume>E67</volume>
          <fpage>o1292</fpage>
          <lpage>o1293</lpage>
        </citation>
      </ref>
      <ref id="B19-crystals-02-01108">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Allen</surname>
              <given-names>F.H.</given-names>
            </name>
            <name>
              <surname>Kennard</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Brammer</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Orpen</surname>
              <given-names>A.G.</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Tables of bond lengths determined by X-ray and neutron diffraction. Part I. bond lengths in organic compounds</article-title>
          <source>J. Chem. Soc. Perkin Trans. 2</source>
          <year>1987</year>
          <fpage>S1</fpage>
          <lpage>S19</lpage>
        </citation>
      </ref>
      <ref id="B20-crystals-02-01108">
        <label>20.</label>
        <citation citation-type="book">
          <article-title>Oxford Diffraction</article-title>
          <source>CrysAlis PRO and CrysAlis RED</source>
          <publisher-name>Oxford Diffraction Ltd.</publisher-name>
          <publisher-loc>Oxfordshire, UK</publisher-loc>
          <year>2010</year>
        </citation>
      </ref>
      <ref id="B21-crystals-02-01108">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sheldrick</surname>
              <given-names>G.M.</given-names>
            </name>
          </person-group>
          <article-title>A short history of SHELX</article-title>
          <source>Acta Cryst.</source>
          <year>2008</year>
          <volume>A64</volume>
          <fpage>112</fpage>
          <lpage>122</lpage>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
